Cargando…

Cognitive measures lacking in EHR prior to dementia or Alzheimer's disease diagnosis

INTRODUCTION: The extent that cognitive measures are documented in electronic health records (EHR) is important for quality care and addressing disparities in timely diagnosis of dementia or Alzheimer's disease (AD). METHODS: Analysis of U.S. EHR data to describe the frequency and factors assoc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Maserejian, Nancy, Krzywy, Henry, Eaton, Susan, Galvin, James E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Featured Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8359414/ https://www.ncbi.nlm.nih.gov/pubmed/33656251 http://dx.doi.org/10.1002/alz.12280

Ejemplares similares

Development of Written Materials for Participants in an Alzheimer's Disease and Related Dementias Screening Trial
por: Head, Katharine J, et al.
Publicado: (2022)

Inferior parietal transcranial direct current stimulation with training improves cognition in anomic Alzheimer's disease and frontotemporal dementia
por: Roncero, Carlos, et al.
Publicado: (2017)

A composite measure of cognitive and functional progression in Alzheimer's disease: Design of the Capturing Changes in Cognition study
por: Jutten, Roos J., et al.
Publicado: (2017)

The relative efficiency of time-to-progression and continuous measures of cognition in presymptomatic Alzheimer's disease
por: Li, Dan, et al.
Publicado: (2019)

Comparison of serum neurodegenerative biomarkers among hospitalized COVID‐19 patients versus non‐COVID subjects with normal cognition, mild cognitive impairment, or Alzheimer's dementia
por: Frontera, Jennifer A., et al.
Publicado: (2022)

Plasma hydrogen sulfide: A biomarker of Alzheimer's disease and related dementias
por: Disbrow, Elizabeth, et al.
Publicado: (2021)

Synaptic biomarkers in CSF aid in diagnosis, correlate with cognition and predict progression in MCI and Alzheimer's disease
por: Galasko, Douglas, et al.
Publicado: (2019)

Central pharmacodynamic activity of solanezumab in mild Alzheimer's disease dementia
por: Willis, Brian A., et al.
Publicado: (2018)

Age‐stratified longitudinal study of Alzheimer's and vascular dementia patients
por: Jørgensen, Isabella Friis, et al.
Publicado: (2020)

General and domain-specific cognitive reserve, mild cognitive impairment, and dementia risk in older women
por: Petkus, Andrew J., et al.
Publicado: (2019)

Detecting early signs of Alzheimer’s disease and related dementia onset from the EHR
por: Schliep, Karen, et al.
Publicado: (2021)

Detecting early signs of Alzheimer’s disease and related dementia onset from the EHR
por: Schliep, Karen, et al.
Publicado: (2021)

A metabolite panel that differentiates Alzheimer's disease from other dementia types
por: Jia, Longfei, et al.
Publicado: (2021)

Time from diagnosis to institutionalization and death in people with dementia
por: Joling, Karlijn J., et al.
Publicado: (2020)

Prevalence of dementia and mild cognitive impairment in indigenous Bolivian forager‐horticulturalists
por: Gatz, Margaret, et al.
Publicado: (2022)

Barriers to Faculty Pedagogical Change: Lack of Training, Time, Incentives, and…Tensions with Professional Identity?
por: Brownell, Sara E., et al.
Publicado: (2012)

Measuring informed consent capacity in an Alzheimer's disease clinical trial
por: Guarino, Peter D., et al.
Publicado: (2016)

Expanding the scope of health disparities research in Alzheimer's disease and related dementias: Recommendations from the “Leveraging Existing Data and Analytic Methods for Health Disparities Research Related to Aging and Alzheimer's Disease and Related Dementias” Workshop Series
por: Akushevich, Igor, et al.
Publicado: (2023)

Clinical and cognitive characteristics of preclinical Alzheimer's disease in the Japanese Alzheimer's Disease Neuroimaging Initiative cohort
por: Ihara, Ryoko, et al.
Publicado: (2018)

Contribution of Alzheimer's biomarkers and risk factors to cognitive impairment and decline across the Alzheimer's disease continuum
por: Tosun, Duygu, et al.
Publicado: (2021)

The impact of an occupational therapy group cognitive rehabilitation program for people with dementia
por: Griffin, Aislinn, et al.
Publicado: (2022)

Alzheimer's disease progression model using disability assessment for dementia scores from bapineuzumab trials
por: Xu, Steven X., et al.
Publicado: (2015)

Polysomnographic assessment of suvorexant in patients with probable Alzheimer's disease dementia and insomnia: a randomized trial
por: Herring, W. Joseph, et al.
Publicado: (2020)

Why do we lack a specific magic anti-COVID-19 drug? Analyses and solutions
por: Lin, Min, et al.
Publicado: (2021)

Neuropathological lesions and their contribution to dementia and cognitive impairment in a heterogeneous clinical population
por: Godrich, Dana, et al.
Publicado: (2022)

Telomere length associations with cognition depend on Alzheimer's disease biomarkers
por: Mahoney, Emily R., et al.
Publicado: (2019)

White matter hyperintensity topography in Alzheimer's disease and links to cognition
por: Garnier‐Crussard, Antoine, et al.
Publicado: (2021)

A simulation study comparing slope model with mixed-model repeated measure to assess cognitive data in clinical trials of Alzheimer's disease
por: Chen, Yun-Fei, et al.
Publicado: (2018)

Apathy in presymptomatic genetic frontotemporal dementia predicts cognitive decline and is driven by structural brain changes
por: Malpetti, Maura, et al.
Publicado: (2020)

Longitudinal patterns of potentially inappropriate medication use following incident dementia diagnosis
por: Ramsey, Christine M., et al.
Publicado: (2017)

Prior Adaptive Semi-supervised Learning with Application to EHR Phenotyping
por: Zhang, Yichi, et al.
Publicado: (2022)

Cognitive and physical markers of prodromal dementia: A 12‐year‐long population study
por: Grande, Giulia, et al.
Publicado: (2020)

Alzheimer's disease assessment scale-cognitive 11-item progression model in mild-to-moderate Alzheimer's disease trials of bapineuzumab
por: Samtani, Mahesh N., et al.
Publicado: (2015)

Baseline demographic, clinical, and cognitive characteristics of the Alzheimer's Prevention Initiative (API) Autosomal‐Dominant Alzheimer's Disease Colombia Trial
por: Rios‐Romenets, Silvia, et al.
Publicado: (2020)

Optimizing the preclinical Alzheimer's cognitive composite with semantic processing: The PACC5
por: Papp, Kathryn V., et al.
Publicado: (2017)

Neural and behavioral substrates of disorientation in mild cognitive impairment and Alzheimer's disease
por: Sousa, Amber, et al.
Publicado: (2015)

Cognitive and structural cerebral changes in amnestic mild cognitive impairment due to Alzheimer's disease after multicomponent training
por: Teixeira, Camila Vieira Ligo, et al.
Publicado: (2018)

Identification of prognostic factors to predict cognitive decline of patients with early Alzheimer's disease in the Japanese Alzheimer's Disease Neuroimaging Initiative study
por: Yagi, Takuya, et al.
Publicado: (2019)

Epigenetic conditioning induces intergenerational resilience to dementia in a mouse model of vascular cognitive impairment
por: Belmonte, Krystal Courtney D., et al.
Publicado: (2022)

A phase 2 randomized, controlled trial of the α7 agonist ABT-126 in mild-to-moderate Alzheimer's dementia
por: Gault, Laura M., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_23q2mbsndv8480i9fl3d8b1u22